Novel frontiers in naso-brain drug delivery;challenges and opportunities
an outlook
Journal name: World Journal of Pharmaceutical Research
Original article title: Novel frontiers in naso-brain drug delivery;challenges and opportunities
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.
Subtitle: an outlook
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Sandeep Kaur, Manoj Kumar Katual, Radhika Sharma, Gurdeep Kaur, S. L. Harikumar
Download the PDF file of the original publication
World Journal of Pharmaceutical Research:
(An ISO 9001:2015 Certified International Journal)
Full text available for: Novel frontiers in naso-brain drug delivery;challenges and opportunities
Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research
Doi: 10.20959/wjpr20174-8215
Copyright (license): WJPR: All rights reserved
Summary of article contents:
1) Introduction
The nasal route of drug delivery has emerged as a promising alternative to traditional administration methods, particularly for therapeutics targeting the central nervous system (CNS). This method utilizes the intricate anatomy of the nasal cavity, allowing for rapid absorption and bypassing the blood-brain barrier (BBB). It facilitates the direct transport of drugs from the nasal mucosa to the brain, making it an appealing option for administering vaccines, proteins, peptides, and non-peptide drugs, especially for conditions like Alzheimer’s and Parkinson’s diseases. The paper explores various aspects of intranasal drug delivery, including mechanisms of absorption, anatomical considerations, and future opportunities within this field.
2) Mechanisms of Nose-to-Brain Transport
The effectiveness of drug transport from the nose to the brain primarily relies on the olfactory pathway, which allows pharmaceutical agents to connect directly to the central nervous system. This region constitutes a small portion of the nasal cavity but is crucial for rapid CNS access, as evidenced by studies tracking fluorescent dyes following intranasal administration. Other potential routes include perineural transport along olfactory and trigeminal nerves, as well as vascular pathways that could facilitate systemic absorption through the highly vascularized nasal mucosa. Understanding these mechanisms is vital for optimizing intranasal formulations for better therapeutic outcomes.
3) Challenges in Drug Absorption
Despite the benefits of using the nasal route for drug delivery, several anatomical and physiological barriers exist that can impede absorption. The primary barrier is the mucus layer covering the nasal mucosa, which consists of a complex mixture of components. Successful drug absorption involves overcoming this barrier and penetrating tight junctions between epithelial cells. Transport methods such as transcellular and paracellular routes, including various endocytic mechanisms, are employed to facilitate the movement of drug molecules. Notably, the size and characteristics of the drug play important roles, with larger molecules facing greater challenges in absorption due to their interactions with mucin and the epithelial membrane.
4) Innovative Nanoparticle Formulations
Recent advancements in nanotechnology have introduced poly(lactic-co-glycolic acid) nanoparticles, solid lipid nanoparticles, liposomes, and nanosuspensions as promising carriers for drugs. These formulations enhance the delivery of therapeutic agents to the brain while minimizing systemic side effects. Polymeric nanoparticles are particularly noted for their ability to carry drugs effectively, providing controlled release and targeted delivery. Moreover, chitosan nanoparticles have shown promise due to their biocompatibility and capacity for encapsulating hydrophilic drugs. These innovative approaches aim to enhance bioavailability and address the limitations of traditional drug formulations for CNS disorders.
5) Conclusion
Nasal drug delivery represents a viable and effective method for circumventing traditional barriers in treating CNS disorders. While the nasal route offers rapid absorption and a bypass to the BBB, challenges associated with anatomical barriers and the physicochemical properties of drugs need to be addressed. The development of nanoparticle-based formulations signifies a step forward in enhancing drug delivery effectiveness and achieving better therapeutic outcomes. Continued research and collaboration across disciplines are critical for refining these delivery mechanisms and ultimately improving the management of brain diseases. As this field evolves, it holds great promise for the future of pharmaceutical therapies directed at the central nervous system.
FAQ section (important questions/answers):
What are the advantages of nasal drug delivery for brain treatment?
Nasal drug delivery offers rapid absorption, non-invasive administration, improved bioavailability, and avoids first-pass metabolism. It allows for convenient self-administration, faster onset of action, and the ability to deliver drugs that cannot be effectively absorbed orally.
How does the nasal route bypass the blood-brain barrier?
The nasal route utilizes the olfactory pathways, allowing drugs to bypass the blood-brain barrier by traveling through olfactory nerve fibers, providing direct access to the brain and central nervous system.
What challenges exist in nasal drug absorption?
Challenges include mucus barriers, potential drug metabolism, tight junction integrity, and insufficient absorption for larger molecules. Nasal conditions like congestion can also impact drug delivery efficiency.
What are some key factors affecting nasal drug bioavailability?
Factors include drug molecular weight, pH of the formulation, viscosity, and presence of absorption enhancers. Each factor can significantly influence the absorption efficiency and bioavailability of drugs delivered through the nasal route.
What types of nanoformulations improve brain drug delivery?
Nanoformulations such as polymeric nanoparticles, liposomes, solid lipid nanoparticles, and chitosan nanoparticles enhance drug delivery to the brain by increasing stability, bioavailability, and targeting efficiency.
What are the limitations of intranasal drug delivery systems?
Limitations include potential mucosal irritation, variability in drug distribution, and possible absorption issues for drugs with higher molecular weights. Frequent use may also lead to damage to nasal tissues.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Novel frontiers in naso-brain drug delivery;challenges and opportunities”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Drug:
A drug is a chemical substance used to treat, cure, prevent, or diagnose a disease. It can affect physiological and biochemical processes in the body, targeting specific conditions like neurological disorders, infections, or pain. Understanding its absorption and effectiveness is crucial in the context of nasal delivery methods discussed.
2) Substance:
Substance refers to a particular kind of matter with specific properties. In pharmacology, it typically denotes any chemical agent, be it a drug or biologically active compound, that interacts with biological systems. The delivery and efficacy of such substances through various routes, including nasal delivery, are central themes in drug research.
3) Blood:
Blood is a vital body fluid that transports oxygen and nutrients to tissues and removes waste products. It plays a crucial role in drug distribution in systemic circulation, impacting pharmacokinetics. The challenge of delivering drugs to the brain, notably due to the Blood-Brain Barrier, is a significant focus of intranasal delivery studies.
4) Disease:
Disease signifies a pathological condition of a bodily part, characterized by an identifiable group of signs and symptoms. Understanding the mechanisms of drug action against diseases, especially those affecting the brain like Alzheimer’s or Parkinson’s, underscores the importance of efficient drug delivery systems, such as nasal routes.
5) Water:
Water is essential for life and plays a critical role as a solvent in biological systems. Its presence affects drug solubility and absorption. In the context of nasal drug delivery, the interaction of water with mucosal surfaces and the formulation impacts the absorption and efficacy of administered drugs.
6) Punjab:
Punjab is a state in northern India, known for its agricultural productivity and educational institutions. Mentioning Punjab in the context of pharmaceutical research highlights regional contributions to healthcare advancements. Institutions in Punjab are engaging in research that seeks to innovate drug delivery systems for brain-targeting therapeutics.
7) Surface:
Surface refers to the outermost layer of an object or material. In pharmacology, the surface characteristics of drug carriers can significantly influence absorption rates and interactions with biological membranes. Enhancing drug delivery across surfaces, like nasal mucosa, is critical for therapeutics targeting the central nervous system.
8) India:
India, a diverse country in South Asia, has made significant strides in pharmaceutical research and development. The advancements in drug delivery technologies, especially intranasal systems, are reflective of the growing emphasis on innovative healthcare solutions in Indian academic and industrial sectors, contributing to global health initiatives.
9) Table:
In research articles, a table organizes and presents data succinctly for easy reference. Tables can include information on drug formulation characteristics, effects of various delivery systems, or summaries of experimental results. They are crucial in conveying complex data effectively, allowing for quick access to essential information.
10) Education:
Education plays a fundamental role in advancing pharmaceutical sciences by equipping individuals with the knowledge and skills necessary for research and development. Institutions that focus on pharmaceutical education, such as those in Punjab, foster innovation in drug delivery systems, significantly impacting healthcare outcomes.
11) Channel:
Channel denotes routes or pathways through which substances move or are transported. In drug delivery, particularly in nose-to-brain transport, various channels facilitate the movement of drugs across barriers like the blood-brain barrier. Understanding these channels is essential for developing effective drug delivery systems.
12) Science (Scientific):
Scientific pertains to methods or approaches based on empirical evidence and the scientific method. In pharmacology, scientific research underpins the development of new drug delivery systems and therapeutic strategies. Advancements in intranasal delivery techniques highlight the importance of rigorous scientific inquiry in improving treatment efficacy.
13) Nature:
Nature broadly refers to the inherent characteristics of the physical world and natural phenomena. In pharmacology, natural compounds and their properties are key to drug formulation and effectiveness. Recognizing the natural interactions between drugs and biological systems enhances the development of targeted delivery strategies.
14) Salt (Salty):
Salt, in a pharmacological context, often refers to ionic compounds formed from the reaction of an acid and a base. Salts can enhance the solubility and stability of drugs, affecting their absorption through delivery systems. Understanding salt forms is crucial in the formulation of intranasal drugs.
15) Pur:
Poor is a descriptor often used in medical literature to denote insufficient quality or effectiveness. In the context of drug absorption or bioavailability, it highlights challenges faced by certain drugs, especially those with high molecular weights that may not be efficiently absorbed through nasal delivery systems.
16) Pharmacological:
Pharmacological pertains to the study of drugs and their interactions with biological systems. It encompasses aspects like drug action, absorption, distribution, metabolism, and excretion. The exploration of pharmacological principles is vital to understanding how drugs can be effectively delivered to target sites, particularly in CNS therapies.
17) Account:
Account refers to a narrative or report detailing events or data. In research, authors provide accounts of their findings regarding drug efficacy, mechanisms of delivery, or biological interactions. These accounts contribute to the collective knowledge and understanding of pharmaceutical advancements and their implications for treatment strategies.
18) Kumar:
Kumar is a common surname in India, often found among researchers and professionals in pharmaceutical sciences. The mention of individuals, like Manoj Kumar in the article, signifies the contributions of these researchers to the field, particularly regarding advancements in drug delivery systems and formulations.
19) Wall:
Wall in biological terms often refers to cellular or anatomical barriers that substances must cross. In drug delivery, understanding the walls of tissues, such as the blood-brain barrier, is key to developing effective routes for medications, particularly through innovative approaches like intranasal delivery systems.
20) Biodegradable:
Biodegradable describes materials that can decompose through natural processes. In drug delivery, biodegradable polymers are preferred as they minimize environmental impacts and enhance patient safety. These materials are used in formulations, such as nanoparticles, for controlled and sustained release of therapeutic agents in intranasal applications.
21) Surrounding:
Surrounding refers to the environment or context within which a substance exists. In drug delivery, the surrounding biological environment can influence absorption, distribution, and the overall efficacy of a drug. Understanding these dynamics is crucial for optimizing formulations for targeted therapy, especially in the CNS.
22) Irritation:
Irritation relates to discomfort or adverse reactions often caused by pharmaceutical products interacting with biological tissues. In nasal drug delivery, considerations for minimizing irritation are essential as they affect patient compliance and therapeutic outcomes. Research focuses on formulating drugs that avoid mucosal irritation while ensuring efficacy.
23) Toxicity:
Toxicity refers to the degree to which a substance can harm humans or animals. Understanding the toxicity profile of drugs is critical in the development of therapeutic interventions, especially for brain-targeting drugs, where minimizing adverse effects while maximizing efficacy is a key challenge in drug delivery research.
24) Activity:
Activity in pharmacological terms relates to the effectiveness of a drug in eliciting a desired biological response. Evaluating the activity of drug formulations, particularly in terms of their delivery mechanisms and targeting capabilities, is essential for selecting appropriate routes, such as intranasal administration, for brain therapeutics.
25) Entering:
Entering refers to the process of a substance moving into a biological compartment or tissue. In the context of drug delivery, examining how drugs enter the systemic circulation or specific organs, like the brain, is vital for understanding pharmacokinetics and developing effective therapeutic strategies, especially through nasal routes.
26) Beating:
Beating, in this context, relates to the movement of cilia in the nasal mucosa, crucial for mucus transport and clearance. Understanding the physiological mechanisms of ciliary beating helps in assessing how drugs can be absorbed through the nasal route and how formulations can affect this natural process.
27) Allergy:
Allergy refers to an excessive immune response to a normally harmless substance. Nasal drug delivery can be complicated by conditions like allergic rhinitis, impacting drug absorption. Research into formulatory strategies that mitigate allergic responses is integral to improving the efficacy of intranasal therapies.
28) Anxiety:
Anxiety is a psychological condition characterized by feelings of worry or fear. The treatment of anxiety disorders may involve pharmacological interventions that require effective drug delivery systems. Understanding how to deliver anxiolytic drugs efficiently through routes such as intranasal administration is a focus in therapeutic pharmacology.
29) Sharman (Sarma, Sarman, Sharma):
Sharma, often a common surname, reflects individual contributions in various fields, including pharmaceutical research. The inclusion of authors like Radhika Sharma in research highlights collaborative efforts and the importance of diverse perspectives in driving advancements in drug delivery systems and therapeutic strategies.
30) Medium:
Medium refers to a state or condition that could relate to the form of a substance, such as a solution or gel used in drug formulations. The characteristics of the medium can significantly influence the solubility and absorption of drugs, pivotal for the effectiveness of nasal drug delivery.
31) Field:
Field signifies a specific domain of study or profession. In this context, the pharmaceutical field focuses on drug discovery, formulation, and delivery systems. Ongoing research in this field aims to improve methodologies, especially for administering treatments to sensitive areas like the CNS via innovative routes.
Other Science Concepts:
Discover the significance of concepts within the article: ‘Novel frontiers in naso-brain drug delivery;challenges and opportunities’. Further sources in the context of Science might help you critically compare this page with similair documents:
Gastrointestinal Tract, Olfactory Pathway, Bioavailability, Blood brain barrier, Intranasal administration, Nasal Mucosa, Pharmacological agent, Mucoadhesive polymer, Permeation enhancer, Chitosan nanoparticles, Nanoformulation, Intranasal drug delivery, Vascularization, Solid lipid nanoparticle, Transcellular transport, Mucus layer, Nose-to-brain transport.